PT Kalbe Farma Tbk KLBF

IDX · Indonesia · Health Technology

IDR 720.00-10.00 (-1.37%)

Market closed· Oct 1, 2026, 9:14 AM UTC· IDR · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

PT Kalbe Farma Tbk KLBF

IDX · Indonesia · Health Technology

IDR 720.00-10.00 (-1.37%)

Market closed· Oct 1, 2026, 9:14 AM UTC· IDR · Data may be delayed

Company news

Yahoo FinanceDec 11, 2025

Kalbe Farma and LIFE AI Unveil StrokeGENME to Personalize Stroke Prevention at National Scale

SINGAPORE, Dec. 11, 2025 (GLOBE NEWSWIRE) -- In a pioneering advancement that aims to reduce the increasing problem of strokes, PT Kalbe Farma Tbk - the largest publicly listed pharmaceutical company in Southeast Asia - through its subsidiary Kalgen Innolab Clinical Laboratory (Innolab) has announced StrokeGENME, a genetics-powered platform that translates DNA insights into individualized stroke-prevention plans, delivered through Kalbe’s nationwide ecosystem. Indonesia’s leading healthcare ente

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.

Prices may be delayed and are for informational purposes only - not investment advice.